Oct 5 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS ANNOUNCES EXPLORATION OF STRATEGIC
ALTERNATIVES
* IMPEL PHARMACEUTICALS INC - INITIATED AN EXPLORATION OF
STRATEGIC ALTERNATIVES
* IMPEL PHARMACEUTICALS INC - CONTINUES TO PROVIDE FULL
COMMERCIAL
SUPPORT BEHIND TRUDHESA, INCLUDING TRUDHESA DIRECT ACCESS
SUPPORT
* IMPEL PHARMACEUTICALS INC - CO CURRENTLY EXPECTS TO
CONDUCT THIS
PROCESS OVER REMAINDER OF 2023
* IMPEL PHARMACEUTICALS INC - GOAL OF CLOSING ANY SUCH
TRANSACTIONS OF PROCESS NO LATER THAN EARLY 2024
Source text for Eikon: ID:nGNX6yJHLt
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))